Login to Your Account

All for One

Immunocore Technology Rouses All T-Cell Comers Against Tumor

By Anette Breindl
Science Editor

Wednesday, May 16, 2012
Researchers at British biotechnology firm Immunocore Ltd., with academic colleagues, have come up with a method to break T-cell tolerance to cancer cells and target tumor-specific proteins, even when those proteins are expressed at very low levels.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription